Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer

Abstract Background The global incidence of prostate cancer (PCa) has been rising annually, and early diagnosis and treatment remain pivotal for improving therapeutic outcomes and patient prognosis. Concurrently, advancements in liquid biopsy technology have facilitated disease diagnosis and monitor...

Full description

Bibliographic Details
Published in:	Cancer Cell International
Main Authors:	Xingyu Zhong, Yuxuan Yang, Haodong He, Yifan Xiong, Mingliang Zhong, Shaogang Wang, Qidong Xia
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Subjects:	Prostate cancer Liquid biopsy Cell-free RNA Biomarker Precision diagnostic
Online Access:	https://doi.org/10.1186/s12935-025-03788-w

Similar Items

Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions
by: Felice Crocetto, et al.
Published: (2025-09-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis
by: Hao Zhang, et al.
Published: (2022-11-01)

Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects
by: Yutong Liu, et al.
Published: (2025-01-01)

Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized Medicine
by: Ovidiu Țica, et al.
Published: (2025-07-01)

Prospective per‐target analysis of the added value of the PrecisionPoint Transperineal Access System in cognitive prostate biopsy of MRI targets
by: Luca Orecchia, et al.
Published: (2024-12-01)

Nurturing the marriages of urinary liquid biopsies and nano‐diagnostics for precision urinalysis of prostate cancer
by: Caizhi Liao, et al.
Published: (2023-02-01)

Editorial: Circulating biomarkers in prostate cancer
by: Masayoshi Nagata, et al.
Published: (2024-02-01)

Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
by: Murad Alahdal, et al.
Published: (2023-09-01)

The diagnostic performance of indocyanine green for the sentinel node biopsy in prostate cancer: A systematic review and meta-analysis
by: Siyang Ma, et al.
Published: (2025-01-01)

Review of diagnostic methods for prostate cancer with consideration of MRI-TRUS fusion biopsy
by: Sebastian Bąk, et al.
Published: (2022-09-01)

The Years 2015–2025 as a Prospective Decade for the Identification of Specific Methylation Biomarkers of Prostate Cancer
by: Zohair Selmani, et al.
Published: (2025-09-01)

DIAGNOSTIC VALUE OF DEFINITION OF FRACTIONS OF PROSTATIC SPECIFIC ANTIGEN AND PROSTATE HEALTH INDEX
by: A. S. Al-Shukri, et al.
Published: (2017-04-01)

Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis
by: Shweta Singh, et al.
Published: (2025-08-01)

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis
by: Lu-Ping Yu, et al.
Published: (2024-09-01)

Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies
by: Riccardo Lombardo, et al.
Published: (2023-08-01)

Comparison of Grading Accuracy of Prostate Cancer in Samples Acquired by a Targeted and Systemic Prostate Biopsy
by: Ivan Pezelj, et al.
Published: (2022-01-01)

Assessment of diagnostic value of unilateral systematic biopsy combined with targeted biopsy in detecting clinically significant prostate cancer
by: Wu Jian, et al.
Published: (2024-10-01)

The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting
by: Yannic Volz, et al.
Published: (2023-08-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy Procedures
by: Timo F.W. Soeterik, et al.
Published: (2025-05-01)

Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken
by: Fabio Zattoni, et al.
Published: (2024-08-01)

Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkers
by: Garima Jain, et al.
Published: (2023-01-01)

Prostate Biopsy: Is it Still Relevant Today?
by: Ritesh Goel, et al.
Published: (2025-04-01)

Multicentre assessment of transperineal targeted prostate biopsy performed as part of a targeted and systematic biopsy diagnostic strategy in men without previous prostate biopsies
by: Mohammed Sheweita, et al.
Published: (2025-04-01)

Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers
by: Eva Chrenková, et al.
Published: (2024-09-01)

Implementing the ESMO recommendations for the use of circulating tumor DNA (ctDNA) assays in routine clinical application/diagnostics
by: Gamisch Alexander, et al.
Published: (2024-08-01)

DNA repair deficiency as circulating biomarker in prostate cancer
by: Martina Catalano, et al.
Published: (2023-01-01)

Evaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer
by: Kui Jiang, et al.
Published: (2025-09-01)

Association Between Prostate Cancer Detection Rate and Year of Prostate Biopsy
by: Young Jun Uhm, et al.
Published: (2025-02-01)

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
by: Marianne Trier Bjerre, et al.
Published: (2020-05-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
by: Simone Scuderi, et al.
Published: (2023-06-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Prostatic Inflammation in Prostate Cancer: Protective Effect or Risk Factor?
by: Alessandro Tafuri, et al.
Published: (2021-06-01)

Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
by: Benjamin M. Mac Curtain, et al.
Published: (2025-04-01)

Prognostic Role of B7-H3 (CD276) Expression in Initial Biopsies of Metastatic Prostate Cancer
by: Adam Yusuf, et al.
Published: (2025-08-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Evaluating liquid biopsies for methylomic profiling of prostate cancer
by: Romina Silva, et al.
Published: (2020-07-01)

Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy
by: Jae Ryun Park, et al.
Published: (2024-09-01)